학술논문
A randomized study investigating the safety, tolerability, and pharmacokinetics of evinacumab, an ANGPTL3 inhibitor, in healthy Japanese and Caucasian subjects
Document Type
Article
Author
Source
In Atherosclerosis December 2020 314:33-40
Subject
Language
ISSN
0021-9150